Oxidative damage caused by reactive oxygen species (ROS) and other free radicals is involved in a number of pathological conditions including cancer. In a population-based case-control study of non-Hodgkin lymphoma (NHL) (n = 518 cases, 597 controls) among women in Connecticut, we analyzed one or more single nucleotide polymorphisms (SNPs) in ten candidate genes (AKR1A1, AKR1C1, AKR1C3, CYBA, GPX1, MPO, NOS2A, NOS3, OGG1, and SOD2) that mediate oxidative stress directly or indirectly in the NADPH oxidase-dependent respiratory burst. Odds ratios (OR) and 95% conWdence intervals (CI) were adjusted for age and race. Polymorphisms in AKR1A1 and CYBA were signiWcantly associated with increased risk of NHL. There was a 1.7-fold (95% CI = 1.2-2.4, P = 0.0047) increased risk of NHL for individuals who were variant homozygous for the AKR1A1 (IVS5 + 282T > C) SNP. The eVect was most pronounced for risk of diVuse large B-cell lymphoma, but risk estimates were non-signiWcantly elevated for other common B-cell histologies and T-cell lymphomas as well. In addition, individuals variant homozygous for the CYBA (Ex4 + 11C > T) SNP had a 1.6-fold (95% CI = 1.1-2.4, P = 0.019) increased risk of NHL that was particularly pronounced for T-cell lymphoma (OR = 3.5, 95% CI = 1.3-9.6, P = 0.013), but was also associated with non-signiWcant increased risks for each of the common B-cell histologies. These results suggest that SNPs in genes related to the oxidative stress pathway may be associated with increased risk of NHL.
Introduction
Oxidative damage caused by reactive oxygen species (ROS) and other free radicals is involved in a number of pathological conditions including ageing and senescence, rheumatoid arthritis, diabetes, atherosclerosis, and cancer (Droge 2002; Poulsen 2005) . ROS, such as oxygen ions, free radicals, and hydrogen peroxides, and other reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent oxygen metabolites are toxic agents as they can oxidize macro-molecules, including lipids, proteins, and DNA (Lawson et al. 1999; Heller et al. 2000; Chaudhary et al. 1994) . NADPH oxidase is one of the most important sources of ROS. Due to its bactericidal activity, the NADPH enzyme system plays an important role in immune protection (Cross and Segal 2004) . It is known that ROS related oxidative stress plays an important role in the pathogenesis of inXammation (Kawanishi et al. 2006; Halliday 2005) . Chronic inXammation and immune-related conditions such as arthritis, Sjogren's syndrome, systemic lumpus erythematosus have been associated with risk of non-Hodgkin lymphoma (NHL) (Baecklund et al. 2006; Smedby et al. 2006; Engels et al. 2005; Xu and Wiernik 2001) .
AKR genes (AKR1A1, AKR1C1, and AKR1C3) are members of the aldo-keto reductase (AKR) superfamily, encode NADPH-dependent oxidoreductase and are involved in catalyzing the reduction of aldehydes (Jez and Penning 2001) . AKR genes can also oxidize polycyclic aromatic hydrocarbon metabolites that in turn produce reactive and redox-active o-quinones which can form DNA adducts or ROS leading to oxidative DNA damage. CYBA encodes the small sub-unit, p22-phox protein, of the cytochrome b 558 of the NADPH oxidase that plays a crucial role in NADPH-dependent ROS production. Endogenous defenses against ROS formation and genomic damage includes superoxide dismutase enzymes, glutathione peroxidase, as well as myeloperoxidase (Bewick 1987) . Superoxide dismutase converts superoxides into hydrogen peroxide, and glutathione peroxidase converts hydrogen peroxide into water. Multiple DNA repair mechanisms exist to avoid the eVects of ROS and maintain genomic integrity (Caporaso 2003) . The most important DNA repair pathway of oxidative damage is base-excision repair (Slupphaug et al. 2003) which includes the enzyme OGG1 (Shinmura and Yokota 2001) .
We have evaluated the inXuence of SNPs in NADPH oxidation related genes, AKR and CYBA genes on NHL risk, as well as SNPs in other genes in related oxidative stress pathways (GPX1, MPO, NOS2A, NOS3, OGG1, and SOD2) (Table 1) , in a population-based case-control study among women in Connecticut. The SNPs analyzed in this study were either chosen on the basis of prior functional data in previous association studies, or to help characterize the haplotype structure of the gene of interest (Danesh et al. 2003; Inoue et al. 1998; Lan et al. 2004; Lightfoot et al. 2006; ShimoNakanishi et al. 2004; Wang et al. 2006 ).
Materials and methods

Study population
The study population has previously been described in detail elsewhere (Morton et al. 2003; Zhang et al. 2004; Zheng et al. 2004 ). BrieXy, from 1996 to 2000, all histologically conWrmed (Revised European-American Lymphoma (REAL) system) incident female NHL cases aged 21-84 years old in Connecticut, alive at the time of interview and without a previous diagnosis of cancer except for non-melanoma skin cancer, were identiWed through the Yale Cancer Center's Rapid Case Ascertainment Shared Resource (RCA). Controls were frequency matched to cases on age ( §5 years) by adjusting the number of controls randomly selected in each age stratum once every several months during the period of recruitment. The study was approved by the Institutional Review Board at Yale University, the Connecticut Department of Public Health, and the (Packer et al. 2006) . For subjects who provided only buccal cells, the amount of DNA was limited. Therefore, we Wrst genotyped DNA from subjects who provided a blood sample. If the results were suggestive or if there was a relatively high prior probability that a given SNP was associated with risk of NHL, we subsequently genotyped those subjects who provided buccal cell samples. Among the 14 SNPs, 10 were genotyped only in subjects who provided a blood sample (Table 1) . Duplicate samples from 100 study subjects and 40 replicate samples from each of two blood donors were interspersed throughout the plates used for genotype analysis. The concordance rates for quality control samples were 99-100% for all assays.
The chi-square test was used to test for departures from Hardy-Weinberg equilibrium among non-Hispanic Caucasian controls. All of the SNP genotype frequencies in the non-Hispanic Caucasian control subjects were in Hardy-Weinberg equilibrium. The ORs were estimated using unconditional logistic regression, adjusting for age (<50 years, 50-70 years, >70 years) and race (white, African-American, other). Further analyses adjusting for family history (Wrstand second-degree relatives) or limited to non-Hispanic Caucasians (representing 93.2 and 91.6% of all cases and controls, respectively) resulted in similar results. In this report, we present results of individual SNP analyses that include all study subjects in all models adjusting for age and race. Gene dosage eVects were evaluated by assigning the ordinal values 1, 2, or 3 based on the genotype, i.e., homozygote wild-type, heterozygote, and homozygote variant. To maximize statistical power, risks for NHL subtypes were carried out using all controls as the comparison group.
For all genes in which more than one SNP was genotyped, haplotype frequencies and analyses were conducted within non-Hispanic Caucasians. HaploView program (http://www.broad.mit.edu/personal/jcbarret/ haploview/) was used to evaluate the haplotype block structure (Barrett et al. 2005 ) the Expectation-Maximization algorithm (ExcoYer and Slatkin 1995) was used to estimate the haplotype frequencies, and the omnibus test that was implemented in SAS Genetics was used to test the overall diVerences in haplotype frequencies between non-Hispanic Caucasian cases and controls, adjusting for age. An unconditional logistic regression model was used to estimate the eVect of individual haplotypes while assuming the most likely The global test of the association between SNPs in the oxidative stress pathway and NHL risk was examined using likelihood ratio Chi-square statistics which compared the logistic regression models that included all SNPs as the main eVects with the null model that included none of the SNPs. To test the robustness of our Wndings, the false discovery rate (FDR) (Benjamini-Hochberg adjustment) method (Benjamini and Hochberg 1995) was applied, which provides the expected ratio of erroneous rejections of the null hypothesis to the total number of rejected hypotheses. The FDR was calculated using results from the additive model (i.e., P-trend), as this permits for minimal degrees of freedom across genotypes. FDR values were calculated from the results of 14 tests (i.e., total number of SNPs studied) evaluating the association between each SNP and the risk of NHL, from the 28 tests of association for risk of B-and T-cell lymphoma, and from the 56 tests of association for four B-cell subtypes.
Results
A greater proportion of NHL cases than controls reported having a family history of NHL and other cancers among relatives (Table 2 ). In terms of age and ethnicity, the NHL cases were comparable to controls. Further analyses which adjusted for family history resulted in similar estimates (data not shown).
Overall, the global test pathway, which incorporates results from all SNPs tested, was borderline signiWcant (P = 0.06), suggesting that genetic variation in the oxidative stress pathway may be important for lymphomagenesis. More speciWcally, individuals homozygous for the AKR1A1 (IVS5 + 282T > C) SNP had a 1.7-fold (95% CI = 1.2-2.4, P = 0.0047) increased risk of NHL (Table 3 ). The eVect was most pronounced for diVuse large B-cell lymphoma (DLBCL) (TT is referent; OR CT = 1.5, 95% CI = 0.9-2.3, P = 0.11; OR CC = 1.8, 95% CI = 1.1-3.1, P = 0.028; P trend = 0.027) ( Table 4) , but risks were non-signiWcantly elevated for other common B-cell histologies and T-cell lymphomas. There was some evidence of association for the AKR1C1 (Ex9 + 68G > A) SNP, particularly for B-cell lymphomas (Table 3 ). We also found that individuals homozygous for the nonsynonomous CYBA (Ex4 + 11C > T) SNP had a 1.6-fold (95% CI = 1.1-2.4, P = 0.019) increased risk of NHL that was particularly pronounced for T-cell lymphoma (OR = 3.5, 95% CI = 1.3-9.6, P = 0.013) (Table 3) , and also associated with non-statistically signiWcant increased risks for each of the common B-cell histologies (Table 4 ). The FDR value for the AKR1A1 (IVS5 + 282T > C) SNP and risk of all NHL was 0.06, which is a relatively low Table 3 Association between AKR1A1, AKR1C1, CYBA polymorphisms and non-Hodgkin lymphoma (NHL) among all NHL, B-and T-cell lymphoma cases and controls and odds ratios adjusted for age and race a For trend tests, the homozygote wild-type, heterozygote, and homozygote variant genotypes were assigned values of 0, 1, and 2, respectively, with the genotype treated as a continuous variable value and indicates that the association may be particularly robust. The FDR value for the CYBA (Ex4 + 11C > T) SNP and risk of all NHL was 0.28. FDR values for B and T cell-speciWc analysis shown in Table 3 , and for the B-cell subtype analyses shown in Table 4 , were above 0.28. Haplotype analysis of all genes with two or more SNPs in linkage disequilibrium showed the same general pattern as observed in Table 3 (Online Supplemental  Table 3 ). Although additional SNPs were signiWcantly associated with one or more NHL subtypes [i.e., NOS3 IVS1-762C > T and T-cell lymphoma (Online Supplemental Table 1) ]; AKR1C3 (Ex1-70C > G) and DLBCL; MPO (642G > A) and follicular lymphoma; and GPX1 (Ex1-226C > T) and marginal zone B-cell lymphoma (Online Supplemental Table 2 ), the number of subjects with the homozygous genotype was either relatively small or there was no indication of a gene dosage eVect. We did not Wnd signiWcant associations between the remaining eleven SNPs and NHL or any subtype (Online Supplemental Tables 1 and 2 ).
Discussion
We evaluated 14 SNPs that were drawn from ten key genes that play a direct or indirect role in mediation of oxidative stress and risk of NHL. Overall, we observed that common genetic variants in genes related to the NADPH oxidase, AKR1A1 and CYBA were signiWcantly associated with an increased overall risk of NHL.
There is increasing evidence that ROS generated by the NADPH oxidase plays an important role in signaling molecules for proliferation of lymphocytes and tumor cells. InXammatory stimuli or infection can trigger a NADPH respiratory burst, which activates the NADPH oxidase system and produces ROS (Almeida et al. 2005) . ROS are also important secondary messengers generated in response to environmental stress and can regulate many cellular actions, including apoptosis, cell diVerentiation and proliferation, often via activation of transcription factors (including NF-B) (Almeida et al. 2005; Sauer et al. 2001) . In response to stress conditions such as infection and inXammation, an inactive form of NF-B present in the cytoplasm can be activated. Activated NF-B transcription factors have been associated with several features of tumorigenesis, including the proliferation, diVerentiation, and survival of lymphocytes (Piva et al. 2006 ). In addition, there is evidence that NF-B activity plays an important role in the pathogenesis of activated B-cell-like DLBCL cell lines (Davis et al. 2001; Alizadeh et al. 2000) , which is critical in lymphomagenesis.
AKRs are NADPH-dependent oxido-reductases involved in both catalytic reactions and in the conversion of aldehydes and ketones into their respective alcohols through the oxidizing of an NADPH cofactor (Jez and Penning 2001) . These enzymes are ubiquitous in nature among mammals, amphibians and plants as well as in lower life forms such as in yeast, protozoa and bacteria. AKRs have a broad substrate spectrum including aliphatic and aromatic aldehydes, monosaccharides, steroids, prostaglandins, and polycyclic aromatic hydrocarbons, which suggests that they may be involved in various biological processes in a variety of tissues. Few published studies have reported associations between AKR genes and cancer, although associations between AKRs and lung cancer and diabetes have been reported Danesh et al. 2003) . It is noteworthy that the only association we report here with an FDR value less than 0.20 was the AKR1A1 (IVS5 + 282T > C) SNP (FDR = 0.06, for risk of all NHL), which provides additional support that this is an important locus for risk of NHL. Additional work is needed to extensively evaluate genetic variants in this locus with respect to risk for NHL, particularly because the functional signiWcance of this intronic SNP is unknown. The AKR1C1 (Ex9 + 68G > A) variant was found to be associated with NHL risk in our study, and is located in the 3Ј untranslated region, which could change gene translation through ribosome binding, initiation, or elongation, and therefore potentially aVect mRNA stability (Kuersten and Goodwin 2003) . Alternatively, the two AKR polymorphisms could be in linkage disequilibrium with other variants in a region associated with increased risk that we did not study.
The SNP (C242T) (His72Tyr) in the CYBA gene located in exon 4, which is found in putative hemebinding sites, results in the replacement of histidine with tyrosine. This SNP has been suggested to have functional relevance for the p22-phox protein because of the structural change it causes in the enzyme structure (Inoue et al. 1998) . One study has shown that compared with the C allele, the T allele conferred an increase in NADPH oxidase activity both in human probands and in cells transfected with CYBA expression constructs (Shimo-Nakanishi et al. 2004 ). However, Guzik reported that the T allele was associated with reduced basal and NADPH-stimulated superoxide production (Guzik et al. 2000) . Similarly, there are inconsistent reported associations between the T allele and diabetes and coronary heart disease (Matsunaga-Irie et al. 2004; Zalba et al. 2005; Santos et al. 2005; Doi et al. 2004 ). Our Wnding that genetic variation in CYBA was associated with risk of NHL, particularly T-cell lymphoma, is consistent with one report that found some evidence that CYBA polymorphisms were associated with risk of T-cell NHL (Wang et al. 2006) . However, the number of cases with T-cell lymphoma in both studies was small and the Wnding requires replication in larger, pooled analyses.
We also found additional SNPs were signiWcantly associated with one or more NHL subtypes. However, the sample size is relatively small, and these could be false positive results (Wacholder et al. 2004) . It is worth noting that the GPX1 Ex1-226C > T was signiWcantly associated with marginal zone B-cell lymphoma, which has been suspected to be associated with chronic inXammation. Lightfoot et al. (2006) recently found that the same variant is associated with an increased NHL risk in both DLBCL and follicular lymphoma. Interestingly, a recent report of microarray Wndings from analysis of tumor samples found that decreased expression of glutathione peroxidase was associated with the worst prognosis for DLBCL patients (Tome et al. 2005) .
Our study has several strengths. It is a populationbased, case-control study with both incident cases that are histologically conWrmed, and highly accurate genotyping data. The primary limitation of our study is that the sample size is modest and the number of cases in several histologic subgroups was small. This resulted in reduced power to detect associations for SNPs with low allele frequencies. Further, the response rate in our study is moderate and could potentially result in biased risk estimates if willingness to participate in our study was associated with genotype frequency. However, a recent report observed that subject participation status was unrelated to genotype frequencies for a wide spectrum of genes (Bhatti et al. 2005) . The positive Wndings in our report require replication in larger studies with greater power, which will be particularly valuable if tagged SNPs with full genomic coverage of the most promising candidate genes are used.
In summary, we report that common genetic variants in the oxidative stress pathway may be associated with the risk of NHL. A detailed, extensive genomic analysis of genes that play a role in the oxidative stress pathway is warranted. Further, these Wndings require replication in larger studies and ultimately in pooled analyses.
